BACKGROUND & AIMS: Pancreatic adenocarcinoma has been associated with several familial cancer syndromes that also predispose to other malignancies. Younger ages of onset of pancreatic cancer (PC) have been reported in families with these syndromes. METHODS: Six hundred twenty-four consecutive patients (probands) from the Mayo Clinic Pancreatic Cancer Patient Registry who completed questionnaires were analyzed for family history of cancer and cigarette smoking. The ages at diagnosis of those probands who reported a family history (first- or second-degree relative) of PC, breast, ovarian, colorectal cancer, or melanoma were compared with those probands who did not. Multivariable regression analyses were performed with age at diagnosis as the primary outcome variable. RESULTS: As expected, smokers had a younger median age of onset of PC than nonsmokers in dose-dependent fashion (P = .0003). After controlling for tobacco exposure and gender, those probands with a family history of breast (-3.23 years, P = .001), ovarian (-5.63 years, P = .005), colorectal (-3.19 years, P = .002) cancers, and melanoma (-5.75 years, P = .017) had a younger age of onset of PC than those who did not. Those with a family history of PC (-.61 years, P = .65) exhibited no difference. Probands reporting other cancers in relatives showed no difference (+.78 years, P = .49) in age of onset of PC. CONCLUSION: A family history of cancers (breast, ovarian, colorectal, melanoma) associated with specific cancer syndromes that are known to contribute also to PC risk is associated with a younger onset of PC. A family history of PC does not appear to affect age of onset of PC.
BACKGROUND & AIMS:Pancreatic adenocarcinoma has been associated with several familial cancer syndromes that also predispose to other malignancies. Younger ages of onset of pancreatic cancer (PC) have been reported in families with these syndromes. METHODS: Six hundred twenty-four consecutive patients (probands) from the Mayo Clinic Pancreatic CancerPatient Registry who completed questionnaires were analyzed for family history of cancer and cigarette smoking. The ages at diagnosis of those probands who reported a family history (first- or second-degree relative) of PC, breast, ovarian, colorectal cancer, or melanoma were compared with those probands who did not. Multivariable regression analyses were performed with age at diagnosis as the primary outcome variable. RESULTS: As expected, smokers had a younger median age of onset of PC than nonsmokers in dose-dependent fashion (P = .0003). After controlling for tobacco exposure and gender, those probands with a family history of breast (-3.23 years, P = .001), ovarian (-5.63 years, P = .005), colorectal (-3.19 years, P = .002) cancers, and melanoma (-5.75 years, P = .017) had a younger age of onset of PC than those who did not. Those with a family history of PC (-.61 years, P = .65) exhibited no difference. Probands reporting other cancers in relatives showed no difference (+.78 years, P = .49) in age of onset of PC. CONCLUSION: A family history of cancers (breast, ovarian, colorectal, melanoma) associated with specific cancer syndromes that are known to contribute also to PC risk is associated with a younger onset of PC. A family history of PC does not appear to affect age of onset of PC.
Authors: Henry T Lynch; Randall E Brand; David Hogg; Carolyn A Deters; Ramon M Fusaro; Jane F Lynch; Ling Liu; Joseph Knezetic; Norman J Lassam; Michael Goggins; Scott Kern Journal: Cancer Date: 2002-01-01 Impact factor: 6.860
Authors: J A Hoppin; P E Tolbert; E A Holly; J W Brock; S A Korrick; L M Altshul; R H Zhang; P M Bracci; V W Burse; L L Needham Journal: Cancer Epidemiol Biomarkers Prev Date: 2000-02 Impact factor: 4.254
Authors: Gloria M Petersen; Mariza de Andrade; Michael Goggins; Ralph H Hruban; Melissa Bondy; Jeannette F Korczak; Steven Gallinger; Henry T Lynch; Sapna Syngal; Kari G Rabe; Daniela Seminara; Alison P Klein Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-04 Impact factor: 4.254
Authors: Gillian S Dite; Mark A Jenkins; Melissa C Southey; Jane S Hocking; Graham G Giles; Margaret R E McCredie; Deon J Venter; John L Hopper Journal: J Natl Cancer Inst Date: 2003-03-19 Impact factor: 13.506
Authors: Stephan A Hahn; Bill Greenhalf; Ian Ellis; Mercedes Sina-Frey; Harald Rieder; Birgit Korte; Berthold Gerdes; Ralf Kress; Andreas Ziegler; John A Raeburn; Donata Campra; Robert Grützmann; Helga Rehder; Matthias Rothmund; Wolff Schmiegel; John P Neoptolemos; Detlef K Bartsch Journal: J Natl Cancer Inst Date: 2003-02-05 Impact factor: 13.506
Authors: Sunil Amin; Russell B McBride; Jennie K Kline; Elana B Mitchel; Aimee L Lucas; Alfred I Neugut; Harold Frucht Journal: Cancer Date: 2011-09-01 Impact factor: 6.860
Authors: C Yuan; J Kim; Q L Wang; A A Lee; A Babic; L T Amundadottir; A P Klein; D Li; M L McCullough; G M Petersen; H A Risch; R Z Stolzenberg-Solomon; K Perez; K Ng; E L Giovannucci; M J Stampfer; P Kraft; B M Wolpin Journal: Ann Oncol Date: 2022-04-06 Impact factor: 51.769
Authors: Li Wang; Kieran A Brune; Kala Visvanathan; Daniel Laheru; Joseph Herman; Christoper Wolfgang; Richard Schulick; John L Cameron; Michael Goggins; Ralph H Hruban; Alison P Klein Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-10-20 Impact factor: 4.254
Authors: Alexis L Norris; Nicholas J Roberts; Siân Jones; Sarah J Wheelan; Nickolas Papadopoulos; Bert Vogelstein; Kenneth W Kinzler; Ralph H Hruban; Alison P Klein; James R Eshleman Journal: Fam Cancer Date: 2015-03 Impact factor: 2.375
Authors: Donghui Li; Jeffrey S Morris; Jun Liu; Manal M Hassan; R Sue Day; Melissa L Bondy; James L Abbruzzese Journal: JAMA Date: 2009-06-24 Impact factor: 56.272